Diclofenac sodium - Actinic keratosis
You are here : Home > Formulary Search > Diclofenac sodium - Actinic keratosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
PAD Profile
ChemicalSubstance :
Diclofenac sodium
Indication :
Actinic keratosis
Group Name :
Keywords :
Diclofenac 3% gel
Brand Names Include :
Solaraze
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Diclofenac sodium is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Actinic keratosis.
Committee Recommendations (2)
Diclofenac 3% gel has been agreed as an appropriate treatment option for aktinic keratosis and may be initiated in Primary Care.
The APC has made recommendations for the primary care treatment choices for actinic keratosis - see treatment guidelines below.
The PCN supported adding Dicofenac 3% (Solaraze) as an additional medical treatment option available for the management of Actinic Keratosis within the licensed indications. It will be considered as green on the traffic light system
(NOTE - a GP should NOT be requested to prescribe as a result of an out-patient referral. It would be appropriate for the Trust to supply the full course in accordance with the Interface Prescribing Policy).
(NOTE - a GP should NOT be requested to prescribe as a result of an out-patient referral. It would be appropriate for the Trust to supply the full course in accordance with the Interface Prescribing Policy).